Clover Biopharmaceuticals, Ltd. (HKG:2197)
Hong Kong · Delayed Price · Currency is HKD 2.760
-0.100 (-3.50%)
May 7, 2026, 4:08 PM HKT
Clover Biopharmaceuticals Market Cap
Clover Biopharmaceuticals has a market cap or net worth of 3.71 billion as of May 7, 2026. Its market cap has increased by 1,316.91% in one year.
Market Cap
3.71B
Enterprise Value
3.41B
Revenue
3.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.76
Market Cap Chart
Since November 5, 2021, Clover Biopharmaceuticals's market cap has decreased from 15.03B to 3.71B, a decrease of -75.30%. That is a compound annual growth rate of -26.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 3.58B | 17.97% |
| Dec 31, 2025 | 3.04B | 871.54% |
| Dec 31, 2024 | 312.59M | -61.08% |
| Dec 29, 2023 | 803.26M | -76.01% |
| Dec 30, 2022 | 3.35B | -78.71% |
| Dec 31, 2021 | 15.73B | 4.62% |
| Nov 5, 2021 | 15.03B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Luzhu Biotechnology | 4.58B |
| Shandong Boan Biotechnology | 4.38B |
| Qyuns Therapeutics | 3.87B |
| BioDlink International Company | 3.83B |
| Mirxes Holding Company | 3.66B |
| TYK Medicines | 3.66B |
| Viva Biotech Holdings | 3.50B |
| Antengene Corporation | 3.29B |